28 septiembre 2015
Mutations in the BRCA 1 and BRCA 2 genes are very likely to lead to a form of cancer in people who have them. These mutations can be detected using a genetic test. The introduction of a new drug has improved treatment options and this, coupled with increased awareness and improved access, increased the number of genetic tests carried out at one hospital last year by a factor of five. As a result, more at-risk patients are picked up and early prevention measures can be commenced.
http://www.sciencedaily.com/releases/2015/09/150928082406.htm
